MedPath

To assess occurrence of peripheral neuropathy in taxane based chemotherapy in patients having Epithelial ovarian cancer.

Not Applicable
Conditions
Health Condition 1: null- Literate spithelial Ca Ovary patients ECOG 0-2 age more than 18 who will be receiving taxane based chemo in adjuvant and neoadjuvant settings
Registration Number
CTRI/2017/09/009603
Lead Sponsor
Tata Memorial Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

1)1.Patients diagnosed with epithelial ovarian carcinoma receiving taxane based chemotherapy in neoadjuvant & adjuvant

2.ECOG PS 0-2 at study entry

3.Patients willing to participate in the Study.

4.Literate patients who can read the translated questionnaires.

5.Age more than 18 years

Exclusion Criteria

No exclusion criteria

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath